Contact

CAS No.:1169630-82-3: The Key to Efficient, Safe GLP-1 Analog Production

Table of Content [Hide]
    Published Date: Apr 09 2025


    Zhuhai Gene-Biocon Biological Technology Co., Ltd. offers Semaglutide Intermediate P29, a critical building block for synthesizing Semaglutide—a leading GLP-1 analog used in diabetes management. Engineered for excellence, our 29-peptide intermediate combines cutting-edge biotechnology with rigorous quality control to empower pharmaceutical R&D and production.

    

    Core Advantages of Semaglutide Intermediate P29

    1. Animal-Free, Risk-Free Production

    Zero Animal-Derived Components: Eliminates risks of viral contamination, prion transmission, or foreign pathogens.

    

    Safe for Regulatory Compliance: Ideal for markets with strict guidelines on animal-origin materials (e.g., EU, US).

    

    2. High Purity & Stability

    Purity ≥90% (HPLC): Ensures consistent performance in downstream synthesis.

    

    Long-Term Stability: Stable for 24 months at ≤-15°C, supported by cold-chain logistics.

    

    Optimized Solubility: Easily dissolves in purified water (pH 11.0–11.5) for seamless integration into synthesis workflows.

    

    3. Scalable GMP Manufacturing

    GMP-Standard Production: Full compliance with global pharmaceutical standards.

    

    Commercial-Grade Supply: Available in bulk quantities with flexible packaging (R&D to industrial scale).

    

    Custom Solutions: Tailored purity, formulation, or documentation support upon request.

    

    Technical Excellence

    Items

    Characteristics

    Source

    E.Coli

    Appearances

    White or off-white freeze-dried powder

    Solubility

    Soluble in water (pH11.0-pH11.5)

    Purity(HPLC)

    ≥90.0%

    Loss on Drying

    ≤10.0%

    Content

    Calculated on a dry basis, the content of Semaglutide intermediate P29 should be ≥ 90.0%


    Application & Workflow Integration

    Semaglutide Intermediate P29 serves as the backbone for synthesizing Semaglutide’s active pharmaceutical ingredient (API). Key steps include:

    

    Dissolution: Reconstitute at 5–10 mg/ml in purified water (pH 11.0–11.5).

    

    Structural Modification:

    Attach an 18-carbon fatty diacid side chain to lysine at position 26.

    

    Link a dipeptide to glutamic acid at position 9.

    

    Purification: High-yield downstream processing to achieve final API quality.

    

    Why Choose Gene-Biocon?

    End-to-End Expertise: From gene engineering to commercial-scale fermentation and purification.

    

    Documentation Support: Comprehensive COA, CERTIFICATE OF ORIGIN, Statement of Animal-free and regulatory guidance.

    

    Reliable Supply Chain: Ice-pack shipping with guaranteed stability during transit.

    

    Compliance & Safety

    For Research/Production Use Only: Not intended for human or clinical applications.

    

    Handling Guidance: Avoid strong acids, oxidizers, or solvents to prevent protein denaturation.

    

    Partner with Confidence

    Elevate your Semaglutide production with a trusted, future-ready intermediate.

    

    Contact Us Today:

    +86-756-6348118 | [email protected]



    References

    Products

    Related Biological Products
    What's New At Gene-Biocon
    All products from the site for Research Use Only. Not for use in diagnostic procedures. Reproduction of any materials is strictly forbidden without permission.
    We use cookies on this site, including third party cookies, to deliver experience for you.
    Accept Cookies
    Read Privacy Policy
    Contact
    Email: [email protected] Tel:+86-756-6348118
    Address:
    11th Floor, Building 4, No. 628 Airport West Road, Zhuhai, GuangDong, China
    Career Partner Program
    All products from the site for Research Use Only. Not for use in diagnostic procedures. Reproduction of any materials is strictly forbidden without permission.